Clinical Trial Update: Combination of Remifentanil and Flurbiprofen in Sedation and Analgesia for ESWL of Pancreatic Stone [Phase 4]

View source ↗

Summary

A phase 4 trial evaluating the combination of remifentanil and flurbiprofen for sedation and analgesia during ESWL of pancreatic stones has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Stone Disease

Drugs mentioned

• Flurbiprofen (flurbiprofen)
• Remifentanil (remifentanil)

Snippet

Sponsor: Changhai Hospital | Conditions: Pancreatic Stone Disease | Phase 4 | Status: COMPLETED